Eco Animal Health (GB:EAH) has released an update.
ECO Animal Health Group reports mixed results in their latest trading update, with Aivlosin gaining market share in key regions like Brazil, India, and the US, but facing challenges in China and Southeast Asia. The company predicts revenues to fall below market expectations for the full year, with adjusted EBITDA estimated to be similar to the previous year. Despite these hurdles, ECO remains optimistic with improvements in China’s pork market and new regulatory approval for Aivlosin in Paraguay.
For further insights into GB:EAH stock, check out TipRanks’ Stock Analysis page.
